Economic outcomes of treatment strategies for type 2 diabetes mellitus and coronary artery disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial.
about
Patient-level costs of major cardiovascular conditions: a review of the international literatureTreatment for stable coronary artery disease: a network meta-analysis of cost-effectiveness studiesIs there an additional benefit from coronary revascularization in diabetic patients with acute coronary syndromes or stable angina who are already on optimal medical treatment?Therapeutic strategies in patients with chronic stable coronary artery disease.Stable angina pectoris: antianginal therapies and future directions.The cost-effectiveness of strategies in coronary artery disease.Revascularization options in stable coronary artery disease: it is not how to revascularize, it is whether and when to revascularize.Medical Therapy With Versus Without Revascularization in Stable Patients With Moderate and Severe Ischemia: The Case for Community Equipoise.Medical therapy v. PCI in stable coronary artery disease: a cost-effectiveness analysis.Cardiovascular Screening for the Asymptomatic Patient with Diabetes: More Cons Than Pros.A systematic review of cost-effectiveness of percutaneous coronary intervention vs. surgery for the treatment of multivessel coronary artery disease in the drug-eluting stent era.Survival outcomes post percutaneous coronary intervention: Why the hype about stent type? Lessons from a healthcare system in India.A systematic review and critical analysis of cost-effectiveness studies for coronary artery disease treatment.
P2860
Q28076912-F5223253-1A3A-4037-AD52-C117BD04444BQ28539350-8AA97A46-50E0-4E89-8B45-3C4281D6FA3EQ35691400-4B7D6190-0A8C-434E-A0BC-41A1683E0BCAQ37759029-5143E228-6D9D-4944-B4A3-4377D2E547EFQ37924086-FE9CBF52-C7A9-45D0-BB54-B51BAF54F799Q38255595-1EEEEE50-06DF-4B3C-9309-2F6668F083D3Q38589870-8DB7B57F-C963-41BB-88A5-1B725DAFA968Q38652030-8F3C1CA9-FC5F-40D5-B661-96BE631D1D1CQ43705921-CFB29D69-1A58-4A10-BADB-C73DA3D3A276Q48128845-2F962BE6-1E49-42D9-9E26-BF966E2D9025Q52900784-C7F1500C-5F7C-4A46-8B52-CC3B93754501Q55333167-271E7DCE-2EEE-4CC7-903F-2FD1BFE4763FQ55690560-C8E4CA23-3589-4BD8-8C2B-D753AFD2FB65
P2860
Economic outcomes of treatment strategies for type 2 diabetes mellitus and coronary artery disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Economic outcomes of treatment ...... nvestigation 2 Diabetes trial.
@ast
Economic outcomes of treatment ...... nvestigation 2 Diabetes trial.
@en
type
label
Economic outcomes of treatment ...... nvestigation 2 Diabetes trial.
@ast
Economic outcomes of treatment ...... nvestigation 2 Diabetes trial.
@en
prefLabel
Economic outcomes of treatment ...... nvestigation 2 Diabetes trial.
@ast
Economic outcomes of treatment ...... nvestigation 2 Diabetes trial.
@en
P2093
P2860
P1433
P1476
Economic outcomes of treatment ...... Investigation 2 Diabetes trial
@en
P2093
Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Study Group
Charanjit Rihal
Derek B Boothroyd
Kathryn A Melsop
Lakshmi Venkitachalam
Laurence Kennedy
William J Rogers
P2860
P304
P356
10.1161/CIRCULATIONAHA.109.912709
P407
P577
2009-11-17T00:00:00Z